2016
DOI: 10.1016/j.intimp.2016.06.004
|View full text |Cite
|
Sign up to set email alerts
|

Anti-inflammatory effects of novel barbituric acid derivatives in T lymphocytes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
12
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 20 publications
(12 citation statements)
references
References 35 publications
(52 reference statements)
0
12
0
Order By: Relevance
“…Although there are some FDAapproved drugs used in treating multiple myeloma with the strategy to suppress NF-kB, theses agents have been thwarted by side effects including nephrotoxicity, neuropathy, and the malignancy (Mina et al, 2016). In previous study, a barbituric acid derivative was found to posse the ability to block IL-2 production in activated Jurkat T cells (Xu et al, 2016). In our animal study, we did not find any body weight lost, liver and kidney damage in BA-5 administrated mice group (Figure 7).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Although there are some FDAapproved drugs used in treating multiple myeloma with the strategy to suppress NF-kB, theses agents have been thwarted by side effects including nephrotoxicity, neuropathy, and the malignancy (Mina et al, 2016). In previous study, a barbituric acid derivative was found to posse the ability to block IL-2 production in activated Jurkat T cells (Xu et al, 2016). In our animal study, we did not find any body weight lost, liver and kidney damage in BA-5 administrated mice group (Figure 7).…”
Section: Discussionmentioning
confidence: 99%
“…Although barbituric acid is not pharmacologically active, it can form a large variety of derivatives called barbiturates that have been used in many ways (Shahzad et al, 2016). Barbituric acid derivatives possess different biological activities, such as hypnotic (Shonle and Moment, 1923;Wisner, 1925), sedative (Kliethermes et al, 2004), anticonvulsant (Srivastava and Kumar, 2004), antimicrobial (Dhorajiya et al, 2014), antiviral (Marecki et al, 2019), anti-inflammatory (Xu et al, 2016), anticancer, and antitumor properties (Singh et al, 2009;Penthala et al, 2015;Laxmi et al, 2016). In 2011, a study showed that a novel barbituric and thiobarbituric acid derivative inhibited high-fat/high-calorie diet-induced nonalcoholic fatty liver disease in male Wistar rats .…”
Section: Introductionmentioning
confidence: 99%
“…The diminution in IL-2 production by BC12 was also observed in a study with primary human and murine T cells stimulated by anit-CD3/anti-CD28 antibodies or by PMA plus ionomycin, respectively. Additionally, both BC12 and BC12-4 inhibited T cell proliferation of murine T splenocytes [56].…”
Section: The Effect Of Selective Pde7 Inhibitors On T Cell Activitymentioning
confidence: 95%
“…PDE7 inhibitors belong to different chemical groups, with wide structural diversity, for example, thiadiazole derivatives [52], sulfonamide derivatives [42], thioxoquinazoline derivatives [53], pyrimidine-based inhibitors [54], furan derivatives [55], or barbituric acid derivatives [56].…”
Section: Potential Therapeutic Use Of Selective Pde7 Inhibitorsmentioning
confidence: 99%
See 1 more Smart Citation